Pfizer Korea wins Lyrica patent suit

Published: 2012-11-02 07:00:00

Updated: 2012-11-02 07:00:00

The Korean Intellectual Property Tribunal has ruled in favor of Pfizer Korea in a patent nullification suit involving Pfizer’s use patent covering Lyrica (pregabalin).

Lyrica is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders.

Ten domestic pharma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK